ENFUSION INC - CLASS A (ENFN) Fundamental Analysis & Valuation

NYSE:ENFN • US2928121043

Current stock price

10.76 USD
-0.04 (-0.37%)
At close:
10.76 USD
0 (0%)
After Hours:

This ENFN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ENFN Profitability Analysis

1.1 Basic Checks

  • In the past year ENFN was profitable.
  • ENFN had a positive operating cash flow in the past year.
  • In multiple years ENFN reported negative net income over the last 5 years.
  • ENFN had a positive operating cash flow in 4 of the past 5 years.
ENFN Yearly Net Income VS EBIT VS OCF VS FCFENFN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

  • The Return On Assets of ENFN (1.97%) is better than 67.61% of its industry peers.
  • With a decent Return On Equity value of 3.86%, ENFN is doing good in the industry, outperforming 68.66% of the companies in the same industry.
  • The Return On Invested Capital of ENFN (3.55%) is better than 73.24% of its industry peers.
Industry RankSector Rank
ROA 1.97%
ROE 3.86%
ROIC 3.55%
ROA(3y)0.28%
ROA(5y)-33.14%
ROE(3y)0.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENFN Yearly ROA, ROE, ROICENFN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

  • The Profit Margin of ENFN (1.40%) is better than 65.14% of its industry peers.
  • In the last couple of years the Profit Margin of ENFN has declined.
  • ENFN has a Operating Margin of 3.05%. This is in the better half of the industry: ENFN outperforms 68.66% of its industry peers.
  • ENFN's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 67.82%, ENFN perfoms like the industry average, outperforming 52.11% of the companies in the same industry.
  • ENFN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.05%
PM (TTM) 1.4%
GM 67.82%
OM growth 3YN/A
OM growth 5Y-33.55%
PM growth 3YN/A
PM growth 5Y-42.1%
GM growth 3Y-1.76%
GM growth 5Y-1.01%
ENFN Yearly Profit, Operating, Gross MarginsENFN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200

8

2. ENFN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ENFN is destroying value.
  • ENFN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ENFN has been increased compared to 5 years ago.
  • ENFN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ENFN Yearly Shares OutstandingENFN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ENFN Yearly Total Debt VS Total AssetsENFN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

  • An Altman-Z score of 12.41 indicates that ENFN is not in any danger for bankruptcy at the moment.
  • ENFN's Altman-Z score of 12.41 is amongst the best of the industry. ENFN outperforms 90.49% of its industry peers.
  • ENFN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.41
ROIC/WACC0.32
WACC11%
ENFN Yearly LT Debt VS Equity VS FCFENFN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

  • ENFN has a Current Ratio of 3.42. This indicates that ENFN is financially healthy and has no problem in meeting its short term obligations.
  • ENFN has a Current ratio of 3.42. This is in the better half of the industry: ENFN outperforms 76.76% of its industry peers.
  • ENFN has a Quick Ratio of 3.42. This indicates that ENFN is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ENFN (3.42) is better than 76.76% of its industry peers.
Industry RankSector Rank
Current Ratio 3.42
Quick Ratio 3.42
ENFN Yearly Current Assets VS Current LiabilitesENFN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

8

3. ENFN Growth Analysis

3.1 Past

  • ENFN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.71%, which is quite impressive.
  • ENFN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.78% yearly.
  • Looking at the last year, ENFN shows a quite strong growth in Revenue. The Revenue has grown by 15.51% in the last year.
  • Measured over the past years, ENFN shows a very strong growth in Revenue. The Revenue has been growing by 27.86% on average per year.
EPS 1Y (TTM)35.71%
EPS 3YN/A
EPS 5Y-22.78%
EPS Q2Q%-25%
Revenue 1Y (TTM)15.51%
Revenue growth 3Y21.76%
Revenue growth 5Y27.86%
Sales Q2Q%13.88%

3.2 Future

  • ENFN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.93% yearly.
  • The Revenue is expected to grow by 15.45% on average over the next years. This is quite good.
EPS Next Y50.32%
EPS Next 2Y40.46%
EPS Next 3Y27.93%
EPS Next 5YN/A
Revenue Next Year16.39%
Revenue Next 2Y16.32%
Revenue Next 3Y15.45%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ENFN Yearly Revenue VS EstimatesENFN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
ENFN Yearly EPS VS EstimatesENFN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

3

4. ENFN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 56.63, which means the current valuation is very expensive for ENFN.
  • The rest of the industry has a similar Price/Earnings ratio as ENFN.
  • Compared to an average S&P500 Price/Earnings ratio of 25.73, ENFN is valued quite expensively.
  • A Price/Forward Earnings ratio of 37.68 indicates a quite expensive valuation of ENFN.
  • Based on the Price/Forward Earnings ratio, ENFN is valued a bit cheaper than 60.56% of the companies in the same industry.
  • ENFN is valuated expensively when we compare the Price/Forward Earnings ratio to 23.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 56.63
Fwd PE 37.68
ENFN Price Earnings VS Forward Price EarningsENFN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 61.97% of the companies in the same industry are more expensive than ENFN, based on the Enterprise Value to EBITDA ratio.
  • ENFN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 58.73
EV/EBITDA 74.97
ENFN Per share dataENFN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ENFN's earnings are expected to grow with 27.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.13
PEG (5Y)N/A
EPS Next 2Y40.46%
EPS Next 3Y27.93%

0

5. ENFN Dividend Analysis

5.1 Amount

  • ENFN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENFN Fundamentals: All Metrics, Ratios and Statistics

ENFUSION INC - CLASS A

NYSE:ENFN (4/17/2025, 8:15:24 PM)

After market: 10.76 0 (0%)

10.76

-0.04 (-0.37%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-03
Earnings (Next)05-08
Inst Owners94.22%
Inst Owner Change-99.92%
Ins Owners3.2%
Ins Owner Change0%
Market Cap1.40B
Revenue(TTM)201.61M
Net Income(TTM)2.82M
Analysts50.91
Price Target11.15 (3.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-26.01%
Min EPS beat(2)-52.94%
Max EPS beat(2)0.93%
EPS beat(4)2
Avg EPS beat(4)-0.65%
Min EPS beat(4)-52.94%
Max EPS beat(4)62.27%
EPS beat(8)2
Avg EPS beat(8)-9.58%
EPS beat(12)5
Avg EPS beat(12)0.54%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.8%
Min Revenue beat(2)-4.7%
Max Revenue beat(2)-2.9%
Revenue beat(4)0
Avg Revenue beat(4)-2.95%
Min Revenue beat(4)-4.7%
Max Revenue beat(4)-1.06%
Revenue beat(8)1
Avg Revenue beat(8)-2.79%
Revenue beat(12)3
Avg Revenue beat(12)-1.79%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.03%
PT rev (3m)7.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.51%
Revenue NY rev (1m)-0.6%
Revenue NY rev (3m)-0.73%
Valuation
Industry RankSector Rank
PE 56.63
Fwd PE 37.68
P/S 6.93
P/FCF 58.73
P/OCF 40.29
P/B 19.08
P/tB 19.08
EV/EBITDA 74.97
EPS(TTM)0.19
EY1.77%
EPS(NY)0.29
Fwd EY2.65%
FCF(TTM)0.18
FCFY1.7%
OCF(TTM)0.27
OCFY2.48%
SpS1.55
BVpS0.56
TBVpS0.56
PEG (NY)1.13
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.97%
ROE 3.86%
ROCE 5.31%
ROIC 3.55%
ROICexc 6.69%
ROICexgc 6.69%
OM 3.05%
PM (TTM) 1.4%
GM 67.82%
FCFM 11.8%
ROA(3y)0.28%
ROA(5y)-33.14%
ROE(3y)0.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-41.88%
ROICexc growth 3YN/A
ROICexc growth 5Y-41.88%
OM growth 3YN/A
OM growth 5Y-33.55%
PM growth 3YN/A
PM growth 5Y-42.1%
GM growth 3Y-1.76%
GM growth 5Y-1.01%
F-Score5
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.67%
Cap/Sales 5.4%
Interest Coverage 250
Cash Conversion 193.66%
Profit Quality 842.72%
Current Ratio 3.42
Quick Ratio 3.42
Altman-Z 12.41
F-Score5
WACC11%
ROIC/WACC0.32
Cap/Depr(3y)104.86%
Cap/Depr(5y)147.45%
Cap/Sales(3y)5.41%
Cap/Sales(5y)5.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.71%
EPS 3YN/A
EPS 5Y-22.78%
EPS Q2Q%-25%
EPS Next Y50.32%
EPS Next 2Y40.46%
EPS Next 3Y27.93%
EPS Next 5YN/A
Revenue 1Y (TTM)15.51%
Revenue growth 3Y21.76%
Revenue growth 5Y27.86%
Sales Q2Q%13.88%
Revenue Next Year16.39%
Revenue Next 2Y16.32%
Revenue Next 3Y15.45%
Revenue Next 5YN/A
EBIT growth 1Y-48.51%
EBIT growth 3YN/A
EBIT growth 5Y-15.03%
EBIT Next Year76.73%
EBIT Next 3Y40.41%
EBIT Next 5YN/A
FCF growth 1Y49.03%
FCF growth 3YN/A
FCF growth 5Y24.73%
OCF growth 1Y35.3%
OCF growth 3YN/A
OCF growth 5Y23.02%

ENFUSION INC - CLASS A / ENFN Fundamental Analysis FAQ

What is the fundamental rating for ENFN stock?

ChartMill assigns a fundamental rating of 6 / 10 to ENFN.


Can you provide the valuation status for ENFUSION INC - CLASS A?

ChartMill assigns a valuation rating of 3 / 10 to ENFUSION INC - CLASS A (ENFN). This can be considered as Overvalued.


How profitable is ENFUSION INC - CLASS A (ENFN) stock?

ENFUSION INC - CLASS A (ENFN) has a profitability rating of 4 / 10.


What are the PE and PB ratios of ENFUSION INC - CLASS A (ENFN) stock?

The Price/Earnings (PE) ratio for ENFUSION INC - CLASS A (ENFN) is 56.63 and the Price/Book (PB) ratio is 19.08.


How financially healthy is ENFUSION INC - CLASS A?

The financial health rating of ENFUSION INC - CLASS A (ENFN) is 8 / 10.